We are leveraging of our expertise in conditional gene targeting, cutting edge multimodal single-cell sequencing, and our great relationship with clinical collaborators to pursue projects related to both basic immunology (B and T cell development) and clinically relevant questions in infection, autoimmunity and cancer.